UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceGlobeNewsWire • 01/19/22
Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceGlobeNewsWire • 01/19/22
RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022GlobeNewsWire • 01/18/22
Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022GlobeNewsWire • 01/06/22
Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect ConferenceGlobeNewsWire • 12/20/21
Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/16/21
Osmotica Pharmaceuticals (OSMT) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • 11/16/21
Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business UpdateGlobeNewsWire • 11/15/21
Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021GlobeNewsWire • 11/15/21
Osmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Update on November 15, 2021GlobeNewsWire • 11/12/21
Analysts Estimate Osmotica Pharmaceuticals (OSMT) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 11/02/21
Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public OfferingGlobeNewsWire • 10/13/21
Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100 MillionGlobeNewsWire • 10/07/21
Osmotica Pharmaceuticals Announces Pricing of $35 Million Underwritten Public OfferingGlobeNewsWire • 10/07/21
Osmotica Pharmaceuticals plc to Present at Cantor Virtual Global Healthcare Conference 2021GlobeNewsWire • 09/22/21
Osmotica Pharmaceuticals plc to Present at H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire • 09/02/21
Osmotica Pharmaceuticals plc Closes Sale of Legacy Business to Alora Pharmaceuticals, LLCGlobeNewsWire • 08/30/21
Osmotica Pharmaceuticals plc (OSMT) CEO Brian Markison on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/17/21